Peroxisome proliferator-activated receptor-γ in the renal mesangium

被引:15
|
作者
Hsueh, WA [1 ]
Nicholas, SB [1 ]
机构
[1] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA
来源
关键词
D O I
10.1097/00041552-200203000-00010
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The peroxisome proliferator-activated receptors (PPARs) are nuclear receptors that are expressed in a variety of tissues, including the liver (PPARalpha), adipose tissue, vascular smooth muscle, the heart, skeletal muscle, and the kidney (PPARgamma). PPARdelta is expressed ubiquitously. The receptors function as transcription factors to regulate the expression of genes involved in lipid metabolism, cell growth and migration as well as insulin-mediated skeletal muscle glucose uptake. Although the mechanisms by which all these actions occur have not been completely worked out, ligands to these receptors function to improve lipid metabolism, insulin sensitivity, endothelial dysfunction and urinary albumin excretion in patients with diabetes. Thus PPARs appear to have enormous implications for the management of cardiovascular disease. Curr Opin Nephrol Hypertens 11:191-195. (C) 2002 Lippincott Williams Wilkins.
引用
收藏
页码:191 / 195
页数:5
相关论文
共 50 条
  • [1] Inflammation in diabetes mellitus:: Role of peroxisome proliferator-activated receptor-α and peroxisome proliferator-activated receptor-γ agonists
    Libby, Peter
    Plutzky, Jorge
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (4A): : 27B - 40B
  • [2] Peroxisome proliferator-activated receptor-γ and lipodystrophy
    Tantsma, Jouke T.
    Rabelink, Ton J.
    [J]. FUTURE LIPIDOLOGY, 2006, 1 (04): : 455 - 462
  • [3] Peroxisome proliferator-activated receptor-γ activity is associated with renal microvasculature
    Guan, YF
    Zhang, YH
    Schneider, A
    Davis, L
    Breyer, RM
    Breyer, MD
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2001, 281 (06) : F1036 - F1046
  • [4] Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ
    Narala, Venkata R.
    Smith, Monica R.
    Adapala, Ravi K.
    Ranga, Rajesh
    Panati, Kalpana
    Moore, Bethany B.
    Leff, Todd
    Reddy, Vudem D.
    Kondapi, Anand K.
    Reddy, Raju C.
    [J]. GENE THERAPY AND MOLECULAR BIOLOGY, 2009, 13 (01): : 20 - 25
  • [5] Peroxisome proliferator-activated receptor-α -: Friend or foe?
    Yagil, Chana
    Yagil, Yoram
    [J]. HYPERTENSION, 2007, 50 (05) : 847 - 850
  • [6] Peroxisome proliferator-activated receptor-γ and esophageal cancer
    Shimada, T
    Terano, A
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2002, 140 (01): : 4 - 5
  • [7] Peroxisome Proliferator-Activated Receptor-γ in Thyroid Autoimmunity
    Ferrari, Silvia Martina
    Fallahi, Poupak
    Vita, Roberto
    Antonelli, Alessandro
    Benvenga, Salvatore
    [J]. PPAR RESEARCH, 2015, 2015
  • [8] Peroxisome proliferator-activated receptor-? cofactors in neurodegeneration
    Katsouri, Loukia
    Blondrath, Katrin
    Sastre, Magdalena
    [J]. IUBMB LIFE, 2012, 64 (12) : 958 - 964
  • [9] Peroxisome proliferator-activated receptor-γ expression in lung
    Inoue, K
    Kawahito, Y
    Sano, H
    [J]. CHEST, 2002, 122 (01) : 386 - 387
  • [10] CIS-DICHLORODIAMMINEPLATINUM UPREGULATES THE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AND ENHANCES THE CYTOTOXICITY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ AGONIST
    Tanaka, Nobuyuki
    Miyajima, Akira
    Hasegawa, Masanori
    Shirotake, Suguru
    Kosaka, Takeo
    Kikuchi, Eiji
    Oya, Mototsugu
    [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E379 - E379